Philippines 3 the aim of the study. An ideal hemostatic dressing that would control bleeding and protect the wound from further contamination is still being sought for combat casualty care. The new SilverLeaf™ (SL) bandage was made of material containing active hemostatic property and possible antimicrobial property from silver coating. This study was conducted to compare and ascertain the hemostatic properties of SL and compare it with known hemostatic dressings: Combat Gauze® (CG) and WoundStat™ (WS) in a swine model with punch, vascular injury. material and methods. Three hemostatic dressings were evaluated in anesthetized Yorkshire swine hemorrhaged for 45 sec in a femoral arterial puncture model. The hemostatic dressings SL, CG, or WS were applied on an actively bleeding wound, followed by 5 minutes of compression at 200 mm Hg. The pressure was then released to baseline and skin closed with towel clamps. After 15 minutes, 500 ml of (Hextend) resuscitation fluid infused over a period of 30 minutes. The animal's vital signs were monitored for the 3-hour experiment period. Primary outcomes documented were incidence of bleeding after application of the dressing, restoration of MAP and rate of survival. Results. The pre-treatment blood loss for WS was 375.66 ml (16.49%), SL 282.08 ml (12.15%) and CG 307.24 ml (12.68%) and was comparable between groups (p>0.56). The post-treatment blood loss for WS was 286.05 ml (10.65%), SL 386.81 ml (16.92%), and CG 525.76 ml (21.52%). There was no significant difference in post-treatment blood loss (p>0.37) between groups. The Mean Arterial Pressure (MAP) did not significantly differ between the groups at all time points compared. The SL and CG had comparable MAPS during the first hour. The SL had a slight advantage, but didn't reach statistical significance. This suggests that all the bandages were comparable. The two time points at which the post-treatment bleeding occurred in the three groups after the release of manual compression and after restoration of blood pressure. The post-treatment re-bleeding rates were 22.22% (2/9) for WS and SL, 44.44% (4/9) for CG. The survival rates were 100% for WS, 88.89% for SL, and 77.78% for CG. conclusion. The findings indicate that SilverLeaf, WoundStat and Combat Gauze were comparable in controlling bleeding, preventing re-bleeding, maintenance of mean arterial pressure and improving survival following treatment.
Hemorrhage is the single major cause of death in potentially salvageable battlefield casualties. Strategies to stop bleeding are limited to tourniquet or compression bandage (1) . The application of circumferential constriction and compression around the limb using tourniquets provide temporary venous and arterial occlusion thus preventing severe blood loss (2) . The use of tourniquets have been acknowledged to save lives during major limb trauma and have widespread military applications. Although tourniquets have a widespread military utilization, prolonged tourniquet application may cause tissue necrosis and eventual limb loss due to cessation of all blood flow below the level of the tourniquet (3, 4) .
There are also limitations to tourniquet application, like vascular trauma to the cervical, abdominal, axillary, and inguinal areas (5) . The reason why it is ineffective in the cervical, axillary and inguinal injuries is because of the anatomic difficulty in achieving proximal control in these areas. The development of fiber, mineral or biological novel materials like chitosan to control bleeding in non-compressible areas has been shown to be promising (6, 7) . Though the Combat Guaze works reasonably well to control hemorrhage. This prototype bandage SilverLeaf™ is an engineered nylon based dressing matrix coated with silver and Chitosan as hemostatic agent at the center of the dressing composite (8) . The use of silver in wound dressings was first tried on burn victims, who were highly susceptible to infection without the protection of skin. The silver not only inhibits the growth of bacteria, but also heals the wound more quickly. This could be due to silver's antimicrobial properties for reducing the risk of infection and fostering more favorable wound healing environment (9) . Hence, the aim of this study is to test a new bandage, prototype SilverLeaf™ (SL) with regard to bleeding arrest, control of re-bleeding after resuscitation, restoration of MAP and survival by comparing it with two bandages, WoundStat™ (WS) and Combat Gauze® (CG).
MATERIAL AND METHoDS

Study design
Hemostatic dressings
The hemostatic products that were used in this study were made of materials with different characteristics. The control dressings were Combat Gauze® (CG, Z-Medica, Wallingford, CT) and WoundStat TM (WS, TraumaCure, Bethesda, MD). CG is a 4-yard long 3-inch wide gauze, rolled in a tight pack. The fabric material (non-woven rayon/polyester) is coated with kaolin. Kaolin is an aluminum silicate, a very potent coagulation initiator that acts as a surface activator (5) . This product has a dry weight of ~16 g and could cover a large area in a groin injury. WS is a smectite/polymer granular product made of aluminum silicate mineral clay containing cations that swell and form plastic clay by absorbing water from blood. CG and WS does not have any exothermic properties in the wound.
SilverLeaf™ (SL, SilverLeaf ™ Technologies, Inc., ontario, Canada) is a prototype made of a silver-coated smooth fiber externally, and a deep-groove fiber internally. It has a dressing matrix with a wicking property that promotes platelet aggregation and an independent inner layer of Poly-D-Glucosamine (Chitosan) at the center of the dressing composite that provides hemorrhage control. The silver component of the dressing provides the potential antimicrobial characteristic to the bandage. Standard dressing (SD; H&H compressed gauze, H and H Associates, Bena, VA) was used on top of the test dressings.
Animal model
The study was approved by the Naval Medical Research Center/Walter Reed Army Institute of Research and Uniformed Services University of the Health Sciences, Institutional Animal Care and Use Committee (IA-CUC). The experiments reported herein were conducted according to the principles set forth in the Guide for the Care and Use of Laboratory Animals, Institute of Laboratory Animals Resources, (National Research Council, National Academy Press, 1996). All procedures were performed strictly in accordance with the Animal Welfare Act and in an animal facility approved by the Association for Assessment and Accreditation for Laboratory Animal Care International (AAALAC).
Yorkshire swine, weighing 30-45 kg (Animal Biotech Industry, ABI; Danboro, PA)) was placed on NPo (nothing by mouth) before the experiment except for water. Pre-anesthetic sedation was given using ketamine HCl (30 mg/kg) intramuscularly and after being weighed, placed on the table and induced using isoflurane 3-4% via mask inhalation; atropine (0.05 mg/kg) was given to reduce mucous secretion. After endotracheal intubation, Isoflurane concentration was reduced to 2-3%. The swine was allowed to breathe spontaneously. If the end tidal Co 2 and respiration rate fell outside normal values, assisted ventilation was provided with manual ambubagging intermittently or as needed. The swine was not placed on mechanical ventilation. An oblique neck incision was made using a No. 10 blade following the right sternocleidomastoid muscle. A venous and an arterial line were established after external jugular vein (EJV) and right carotid artery (RCA) dissection and isolation. Both vessels were cannulated; a 20 gauge angiocatheter was placed in the right carotid artery and a 9F introflex introducer in the right EJV. The vital signs were continuously monitored and recorded. The EJV (venous line) was used for fluid resuscitation and the RCA (arterial line) was used for monitoring arterial pressure and heart rate, and for blood sampling. The arterial line was connected to sensors (Transpac IV, Trifurcated Monitoring Kit, Hospira, Lake Forest, Il) attached to a hemodynamic monitoring system (Hewlett Packard, Palo Alto, CA) that allowed continuous monitoring and recording of arterial blood pressure, heart rate and arterial oxygen saturation. The catheter was continuously flushed with 0.9% saline solution (5 ml/hr) to maintain patency. Pulse oximetry (Datex-ohmeda/V3301, SurgiVet, Waukesaha, NJ) was obtained from the tongue. A rectal temperature probe was also inserted for continuous monitoring of core temperature and thermoregulation was set to 37-39°C. Wound temperature was also monitored using a temperature probe (Type K, Thermo-Couple Thermometer/Model BAT12, Physitemp, Clifton, NJ) that was placed inside the inguinal cavity near the femoral artery to monitor change in wound temperature when the bleeding was started and the dressing was applied. Splenectomy was not performed in these animals.
Puncture model
An inguinal incision was made following the inguinal crease starting 2 cm from the anterior superior iliac spine and ending 2 cm from the pubis. The incision was about 10 cm in length. The common femoral artery was then dissected and isolated freeing approximately 5 cm of the vessel free of fascia tissue. The internal femoral artery was then dissected, isolated and a loop ligature was placed to avoid bleeding from proximal and distal clamping of the main artery. once the baseline parameters were taken, proximal and distal control was achieved using peripheral vascular clamps. A stab incision on the anterior wall of the artery was then made using a No. 11 blade just enough for the aortic punch to fit. once inside the lumen, the aortic punch (APU440, Medtronic, Minneapolis, MN) was used to make a 4mm hole on the anterior arterial wall. The vascular clamps were then removed to produce uncontrolled hemorrhage [time 0 (T0)] resulting in immediate release of high pressure arterial blood. The shed blood accumulating in the wound site was suctioned using a Yankauer (Conmed, Beaverton, oR) at the surface of the cavity to prevent it from spilling, both ends of the inguinal incision were held up by towel clips. The Yankauer suction tip was not directed towards the injured vessel. The suctioned blood went directly to a suction container atop a digital weighing scale for continuous monitoring of weight. The blood collected was recorded as pre-treatment blood loss. Because of the high shear stress bleeding and shed blood accumulation, blood was still present in the wound cavity at the time of dressing application.
Treatment and monitoring
After an uncontrolled bleeding for 45 seconds, (T1) the treatment consisted of placement of the randomized test dressing on the injured site with a standard gauze dressing placed on top of it, which was rolled around a neonatal blood pressure cuff Critikon® (3-6 cm circumference) inflated at 40 mm Hg. The test dressings were applied as per manufacturer's directions. Manual compression was applied over the randomized test dressing and standard gauze containing the blood pressure cuff until a pressure of 200 mm Hg was delivered and sustained for 5 minutes. Pressure was released after 5 minutes (T5) and maintained at a baseline residual pressure of 40 mm Hg. The wound, still with the gauze and dressing inside was then temporarily closed with towel clamps opposing the skin edges for the remaining 3 hour duration of the experiment (T180). every 5 minutes for the first hour and every 15 minutes thereafter.
In vitro measurements
Blood samples (10 ml) were withdrawn through the arterial line at Time 0, 5, 15, 45, 60, 120 and 180 minutes. Arterial blood gas (ABG), chemistry, hematology and electrolytes were measured on the Stat Profile ®Critical Care Express Analyzer (Nova Biomedical, Waltham MA).
Statistical analysis
The design of the study was to evaluate prototype SilverLeaf TM (SL) bandage in comparison to WoundStat TM (WS) and Combat Gauze® (CG) as controls on 9 animals in each group. Prior to surgery, randomization was done to determine which bandage was to be used. one-way analysis of variance (ANoVA) was used to compare the mean weight and EBV among the groups. one-way analysis of covariance (ANCoVA) was used to compare the mean blood volume loss (pre, post and total) among the groups after adjusting for weight. Repeated measures analysis of variance was used to compare the groups over time with respect to baseline, drops, and recovery of Hemoglobin (Hgb), Hematocrit (Hct), and MAP. A mixed model approach with an unstructured covariance matrix was used in order to accommodate the missing data. The model included the main effects of bandage and time, and the bandage x time interaction term. Based on these results, the linear contrast method was used to compare the three bandages at each time point. The proportion of pigs experiencing "re-bleed" was compared across groups using Fisher's exact test. Survival curves were estimated using the Kaplan-Meier method and compared using the Log-rank test. All the tests were performed using SAS version 9 for Windows (SAS Institute, Inc., Cary, NC). Data presented as mean ± standard deviation and p<0.05 was considered significant. The dressings were initially ranked according to survival rate as survival of the animals across the 3 hour experiment is directly affected by quantitative blood loss.
Histology
Histologic examination was also performed for each bandage group. The distal tissue (including muscle, vessel and nerve) was colAt 15 minutes (T15), 500 ml of fluid resuscitation was given using isotonic colloid fluid (Hextend, Biotime, Abbott, CA). The fluid was given through the EJV line for 30 minutes until T45 using a Masterflex pump set at 1L/h (Cole Parmer, Vernon Hills, IL) corresponding to ~ 15 ml/kg and no additional fluid was administered regardless of the mean arterial pressure (MAP) or the blood loss. The animal was observed for the entire duration of the experiment for post-treatment bleeding. once the 3-hour endpoint was reached (T180), the animal was euthanized with pentobarbital sodium and phenytoin sodium (Euthasol® solution) at 0.3 ml/kg via intravenous injection.
Estimated blood volume (EBV) was calculated as: animal weight (kg) x 70 ml/kg. Estimated blood volume loss (EBVL) was calculated using the blood weight (g) as: weight (g)/1.056 g/ml. Blood loss was divided into pretreatment blood loss (induced 45 seconds bleed) and post-treatment blood loss (bleeding observed after bandage application). Post-treatment shed blood was continuously recorded. Shed blood contained in the test and standard dressing were weighed at the end of the experiment. Each product was evaluated for recurrence of bleeding following release of 5 minutes of manual compression and following mean arterial pressure (MAP) restoration close to baseline level. MAP is computed as diastolic blood pressure plus one third of the pulse pressure (PP).
PP ≈ SBP -DBP MAP ≈ DBP + 1/3 (SBP -DBP) DBP (diastolic blood pressure); SBP (systolic blood pressure)
Data collection and processing
Recording and data acquisition
The shed blood was collected in a sealed container (2L MediVac, Cardinal Health, Dublin, oH) and continuously weighed on a toploading scale (Mettler, PS 5100). Rectal and wound temperature (at the interface of blood and dressing) were continuously recorded using temperature probes (BAT 12, PhysiTemp, Clifton, NJ). Blood pressure (MAP, diastolic, systolic) and heart rate (HR) were continuously monitored using a blood pressure analyzer (BPA) (Micro-Med Inc, Louisville, KY). The Co 2 , Isoflurane level, respiration rate, and oxygen saturation were recorded manually lected after the dressing was removed. The tissue was fixed in 10% formalin, embedded in paraffin, microtomed (6 µm) and stained with hematoxylin and eosin (H&E). Tissues were examined with light microscopy (LM) by a pathologist who was blinded to treatment group. The following parameters were noted: presence of edema, presence of fibrin or thrombi, potential for burn injury, foreign body, necrosis and, neutrophil influx. The tissue sections were scored and observations were graded as mild, moderate, and severe, and characterized as focal, multifocal, and diffuse.
RESULTS
A total of 27 swine were used in the puncture injury model (n= 9 animals per group) for CG, WS and SL. one-way analysis of variance (ANoVA) was used to compare the mean weight and EBV among the groups. Though there were no significant differences among groups (p = 0.4784), the test dressing is comparable with the hemostatic dressing that is currently being used in the battle field, Combat Guaze. Mean weight and estimated blood volume are shown in tab. 1.
one-way analysis of covariance (ANCoVA) was used to compare the mean blood volume loss (pre-treatment, post-treatment and total) among groups after adjusting for weight ( fig.  1 ). There were no significant differences among the groups. Pre-treatment blood volume loss (BVL) was highest with WS (357.67 ± 46.1 ml) followed by CG and SL. Post-treatment BVL was highest with CG (525.76 ± 155.5) followed by SL and WS.
All animals had normal hematology and serum chemistry parameters. A repeated measure of analysis of variance was used to compare the groups over time with respect to Hgb, Hct, and MAP. This study is specifically designed to test the main effect of bandage, which assesses the extent to which different bandages have different outcomes for all time periods combined. The bandage x time interaction would assess whether the pattern of responses over time varies with bandage. The change in the pattern of MAP with response to the type of bandage has been presented in fig. 2 
Animal survival and bleeding control following treatment
The proportion of pigs experiencing rebleeding was compared across groups using Fisher's exact test. Re-bleeding was noted minutes after release of manual compression, and during increase of the MAP close to baseline after fluid resuscitation (recovery period). The re-bleeding in Silverleaf™ (SL) group did not significantly differ from either the Woundstat™ (WS) or Combat® (CG) groups. Rebleeding rates were 44% (n= 4/9) for CG, and 22% (n=2/9) each for SL and WS. 4 and tab. 3 ).
Histology
The proportion of specimens exhibiting hemorrhage, edema, fibrin, foreign body, neSurvival curves were estimated using the Kaplan-Meier method and compared using the log-rank test. There was no statistically significant difference in survival between groups. Survival rates were CG 77.78% (n=7/9), SL 88.89% (n= 8/9) and WS 100% (n=9/9). Mean Survival times were 159.89 (2'40'') CG, 178.33 min (2'58") SL and 180 min (3'00'') WS. There was 1 death in the SL group that succumbed to hemorrhagic shock due to uncontrolled posttreatment bleeding (p = 0.3152 vs. CG and WS). Survival plots are shown in fig. 3 .
Wound temperature overall there were significant differences between inguinal (wound) and rectal (core) temperatures (averaging over all animals and time points, p<0.001) and that the difference between core and wound temperatures varied with both time and type of bandage (p=.03). crosis, and inflammation were compared among bandages using Fisher's exact test. Periarterial hemorrhage was noted in all specimens (tab. 4A, fig. 5 ). Focal periarterial hemorrhage was found greatest in CG 6/9 (66.67%), followed by WS and SL. Multifocal periarterial hemorrhage was found greatest in SL 5/9 (55.55%), followed by WS and CG. Periarterial fibrin was shown most in WS, and WS granules were present in the specimens and were read as foreign materials ( fig. 6A-C) . Inflammation was present in 3/9(33.33%) specimens in WS and SL and 1/9 (11.11%) in CG ( fig. 7) . The SL is comparable to CG and WS in arresting bleeding and preventing rebleeding (tab. 5). one thrombus was found in WS ( fig. 8 ). All these findings were shown in tab. 4B and were not found to be statistically significant except for the presence of foreign material in WS 9/9 (100%) as seen in fig. 8 , compared to the absence of foreign material in other two groups (p<0.001). The SL bandage is comparable to WS in arresting bleeding and preventing re-bleeding. In addition SL exhibited ease of application and ease of removal comparable to CG. Since the granular matrix of WS was built to absorb blood it was observed to have the best absorption, however it was not ideal when it comes to ease of removal. Since this forms a mud like consistency after it absorbs blood, the cleaning of the wound for vessel reconstruction has proven to be a challenge (tab. 5).
DISCUSSIoN
SilverLeaf™ is a prototype dressing designed to combine a hemostatic and an antimicrobial effect on the wound by impregnating Chitosan haemostatic granules into the nylon dressing matrix. The wicking property of the nylon matrix is supposed to promote platelet aggregation, while the silver component of the dressing is supposed to confer an antimicrobial property (10) . This combination provides it a promising application potential in the field. The findings in this study indicated that SilverLeaf (SL), WoundStat (WS) and Combat Gauze (CG) were comparable in controlling blood loss, preventing further re-bleeding, maintenance of mean arterial pressure and improving survival following treatment.
SL's design sets the bandage snugly by conforming to the wound cavity and gives it ease of application and removal. Combat Gauze® and Woundstat™ were the dressings that have been tested previously for combat casualty care applications (11, 12, 13) , but subsequently only the Combat Guaze was approved as the main dressing for combat casualty care by the US Army. In this study, these two bandages were used as controls and compared to SL with regard to performance in arresting bleeding in a femoral vessel punch (partial transection) model. A partial transection of the vessel allows us to achieve uncontrolled hemorrhage by taking away the natural tendency of arterial vessels to constrict and retract following complete arterial transection in an attempt of the body to achieve temporary hemostasis. After the initial insult it now becomes a challenge to arrest bleeding by bandage application and manual compression to prevent re-bleeding that occurs with adequate resuscitation. Though there were slight changes in the wound temperature and core temperature, no clinical significance could be attached because the normal body temperature of the pig is about 39 o C. Although WS showed a 100% survival, it still provides a challenge to the vascular surgeon as this product develops a mud like substance with sandy granules after it absorbs blood. It adheres to the tissue and cleaning of the wound would be a big challenge. WS granules caused endothelial injury and significant transmural damage to the vessels that renders them nonviable for primary surgical repair. The granules can enter systemic circulation and cause distal thrombosis in vital organs (14) . This has been reported in an earlier study, subsequently the purchase and distribution and usage of WS have been permanently halted in US military and the US army. Hence, the CG has been recognized as the first line of haemostatic agent to treat into play in choosing the next generation of bandages. The antimicrobial property of this bandage is yet to be studied. Though this prototype SL bandage has a good potential to be an effective hemostatic bandage, the smaller sample size is a major limitation of this study and it has to be tested in a larger study to conclusively prove that it is as effective as the other currently available products in the market or possibly even superior product.
The comparable performance of SL in bleeding control, prevention of re-bleeding and survival rate could be attributed to the type of fiber, composition of the material used to manufacture this dressing. The absorption ability of the fibers used for making this bandage and active hemostatic properties of biological material chitosan and antimicrobial property of the silver coating could provide further advantage for bleeding control along with possible infection control in actively bleeding wounds. This study suggests that SilverLeaf bandage could possibly be a useful hemostatic dressing with potential anti-microbial properties for pre-hospital combat casualties and supports further study to confirm its efficacy.
external bleeding in the battlefield (15). Besides hemorrhage control, it is also important to take into account of ease of application, ease of removal of the dressing in the combat setting, where the soldiers could be alone or under enemy fire. Besides effectiveness, other factors such as removal of dressing for subsequent surgical repair of the wound, size, weight and cost could play a major role in selecting the right kind of bandage for combat casualty care applications.
This study does have certain other limitations. When the study was designed, the option to study two additional control groups (no bandage and standard gauze) to show placebo effect were carefully considered. Since the standard gauze was already tested in our laboratory earlier, the CG and WS has been shown to consistently increase the survival rate as compared to standard gauze (15, 16).
The standard gauze was not tested in this study. In addition, the CG is the standard of care in the combat casualty and testing of SD or control group would not add any new information to the already existing scientific knowledge. Though the post-treatment blood loss and MAP is slightly better than the control group CG, the overall survival rate among all three product groups is either equally effective or comparable. It is possible that, the SL was better and hadn't reached statistical significance due to smaller sample size and limited experimental data to reach any definitive conclusion. CoNCLUSIoNS overall, SL was comparable to WS and CG in providing initial hemostasis, preventing re-bleeding, improving MAP and increasing the rate of survival during the 3 hr experimental period. Though there was no statistical difference in survival as compared to other two bandages, the SL has good efficacy and was a comparable product to CG in this limited study. As new bandages are compared to those that are currently in use, it is difficult to show a clear advantage in hemorrhage control and increase in survival rate of the new ones sufficient to displace those that are already in use. Proposed new bandages must be at least as good as those that are currently in use to be considered. Then other factors such as, cost, ease of use, ease of removal, and infection control are additional benefits that may come
